A clinical trial to assess the effect of Leech therapy in patients of venous ulcer

A Single arm clinical study to evaluate the wound healing efficacy of Jalaukavacarana in the managemnet of venous ulcer (Dusta Vrana) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/078515

Enrollment

Registered

2024-12-24

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I868- Varicose veins of other specifiedsites

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient of age between 18 to 60 years and of both the genders. 2. Active venous ulcers. 3. History of recurrence of venous ulcers. 4. Duration of ulcer up to 3 years. 5. Patient having Hb percentage greater than 10 gm/dl 6. Patients with controlled hypertension and diabetes. 7. Patients who fulfill any three symptoms of the above mentioned diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women. 2. Uncontrolled Hypertension and diabetes. 3. Duration of ulcer more than 3 years. 4. Known case of diseases like STDs, TB, heart diseases and other disorders which lead to fatal condition for the patients. 5. Patients having embolism, bleeding disorder, and other infective skin disorders. 6. Patients with immune-compromised diseases like HIV, HbsAg, and HCV etc. 7. Patient having Hemoglobin percentage lower than 10 gm/dl 8. Other types of wounds such as Malignant wound, tuberculous wound, leprosy ulcer, and syphilitic ulcers.

Design outcomes

Primary

Measure	Time frame
To check the efficacy of Jalaukavacharana in the patient of venous ulcer by below given points: 1. Vedan ? (pain) 2. Gandha (Odour of discharge) 3. Vará¹?a â?? (Skin Colour Surrounding Wound) 4. Kaá¹? ?u (Itching) 5.Venous Clinical Severity Score (VCSS) 6.Wound Measurement 7.Others Timepoint: 8 Weeks	—

Secondary

Measure	Time frame
To observe the changes in Venous clinical severity score (VCSS)Timepoint: 8 Weeks	—

Countries

India

Contacts

Public ContactProf Dr Kalapi B Patel

J S Ayurveda Mahavidyalaya and P D Patel Ayurvedic Hospital

drkalapi@rediffmail.com9428661664

Outcome results